A Prospective Evaluation of Infraorbital Filler Injection

Completed · Not applicable

Conditions studied: Dermal Filler, Rejuvenation

In brief

The goal of this clinical trial is to measure the facial volumetric changes over time in patients injected with hyaluronic acid dermal filler (Juvéderm Volbella XC) in the infraorbital (under eye) region. Participants will be injected with Juvéderm Volbella XC filler and asked to return for 3D photography at 2 weeks, 1 month, and 3 months post-injection.

Key facts

Study ID

NCT05694286

Run by

University of Pennsylvania

People needed

11

Starts

2023-01-06

Expected to finish

2023-06-29

Last updated by the study team

2025-01-08

Who can join

Age: 22 and older, up to 65. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• female
• age 22 to 65
• interested in filler injections to reduce undereye volume loss

You may not qualify if…

• male
• age <22 or >65
• prior undereye filler
• filler/neurotoxin injection within the past 12 months
• prior facial cosmetic surgery
• prior facial trauma
• planned dental work within next 2 weeks
• travel 1 week prior or 2 weeks after injection

Where it is running

• Penn Medicine — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.